August 3, 2017
Oncolytics Biotech revealed their financial results for the second quarter of 2017.
July 31, 2017
uniQure N.V. entered an agreement with Chiesi Group to reacquire the rights to co-develop and commercialize its hemophilia B gene...
May 18, 2017
Oncolytics Biotech revealed the publication of new data from two new studies, set to be presented at the upcoming American...
May 8, 2017
Oncolytics Biotech announced the US Food and Drug Administration granted a fast track designation for Reolysin, an immuno-oncology viral agent...
May 5, 2017
Oncolytics Biotech released their financial results for the first quarter of 2017.
April 12, 2017
Oncolytics Biotech announced its initial registration pathway and clinical development plan for REOLYSIN, their immuno-oncology viral agent.